Forward P/S Multiple: Novanta (NOVT)

Novanta Inc. - graphic logo of issuer NOVT

Novanta Inc. is implementing sustainable standards in the development of photonic systems. Stable cash flows are supported by long-term demand for components, while high margins are based on the complexity of replacing OEM solutions. The forward P/S ratio visualizes the market valuation relative to expected revenue, with 1.30 serving as the current value of the parameter.

novanta.com - NOVT Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Novanta Photonics (NOVT)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:NOVT (Novanta)
Product sample of Novanta Photonics

Forward P/S evaluates market capitalization relative to expected revenue, allowing for the determination of the premium paid for future income streams. By analyzing the current forward P/S level on the GURU.Markets platform, an investor can see the monetization efficiency of Novanta Inc. high-precision lasers, where demand for critical robotic medicine components confirms the business's fundamental value even amidst market volatility.

Who Novanta Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Haemonetics Corp. - Forward P/S Multiple|Market Cap to Future Revenue Ratio Inspire Medical Systems Inc|PRCT: Forward P/S Multiple|Market Cap to Projected Revenue CNMD|PLSE (Pulse Biosciences) - Forward P/S Multiple|InMode Ltd (INMD) - Market Cap to Expected Sales Ratio|Forward P/S Multiple PMI|Forward Price-to-Revenue Multiple Surmodics Inc. SRDX|Forward P/S Multiple SENS (Senseonics Holdings)|Forward P/S Multiple neuropace.com NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|OM (Outset) - Forward Price-to-Revenue Multiple|Electromed - Forward Price to Sales|LNSR (LENSAR, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio avitamedical.com RCEL|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|beyondair.net (XAIR) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue PFSA|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|Market Cap to Future Revenue Ratio glucotrack.com GCTK|Forward Price-to-Revenue Multiple NAOV (NanoVibronix)|Price-to-Projected Revenue Ratio VERO (Venus Concept Corporation)|Forward P/S Multiple NUWE (Nuwellis, Inc.)|Forward P/S Multiple aethlonmedical.com AEMD|ASXC - Price-to-Projected Revenue Ratio|AVGR (Avinger Inc.) - Market Cap to Projected Revenue|BSGM (BioSig Technologies, Inc) - Forward Price-to-Revenue Multiple|CUTR: Price to Expected Revenue Ratio|KNW (Know Labs, Inc.) - Forward P/S Multiple|Forward P/S Multiple inarimedical.com|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical Inc.)